Amanta Healthcare Limited (NSE:AMANTA)

India · Delayed Price · Currency is INR

128.67

+7.64 (6.31%)

At close: Apr 16, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2010	FY 2009
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '10 Mar 31, 2010	Mar '09 Mar 31, 2009
Manufacturing and sale of pharmaceutical products	2.75B	2.80B	2.59B	2.25B	1.71B
Manufacturing and sale of pharmaceutical products Growth	-2.01%	8.19%	14.94%	31.61%	-7.09%
Total	2.75B	2.80B	2.59B	2.25B	1.71B
Total Growth	-2.01%	8.19%	14.94%	31.61%	-7.09%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2010	FY 2009
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '10 Mar 31, 2010	Mar '09 Mar 31, 2009
India	1.81B	1.96B	1.77B	1.59B	1.10B
India Growth	-7.67%	10.67%	11.47%	45.16%	-16.69%
outside India	908.31M	821.71M	801.85M	648.95M	593.33M
outside India Growth	10.54%	2.48%	23.56%	9.37%	16.75%
Total	2.72B	2.78B	2.58B	2.24B	1.69B
Total Growth	-2.30%	8.12%	14.97%	32.59%	-7.37%

Source: S&P Global Market Intelligence.